Literature DB >> 1728410

Eosinophils, tissue eosinophilia, and eosinophil-derived transforming growth factor alpha in hamster oral carcinogenesis.

M Ghiabi1, G T Gallagher, D T Wong.   

Abstract

Eosinophilia in tissues and/or circulating blood is known to be associated with a wide variety of malignancies but the role of the eosinophil in neoplastic conditions is not known. Using the cheek pouch of the Syrian hamster as an experimental model for oral carcinogenesis, it has recently been shown that eosinophils at sites of developing oral cancer express the multifunctional cytokine, transforming growth factor alpha (TGF-alpha). This study investigated the time course of eosinophil infiltration, tissue eosinophilia associated with malignant epithelium, and eosinophil-derived TGF-alpha mRNA during the 16-week 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral cancer development process. The results reveal that the occasional eosinophil is normally present in the lamina propria of hamster oral mucosa. With progressive DMBA treatments, there is an increase of eosinophils infiltrating into the lamina propria. By weeks 12-16, the number of eosinophils is significantly higher in DMBA-treated pouches than in control pouches treated with the vehicle mineral oil alone. Analysis of the infiltrating eosinophils into fully developed hamster oral carcinomas reveals that tissue eosinophilia is associated with 78% of the stromal areas associated with malignant epithelium, while only 7% of sites associated with non-tumor oral epithelium (normal, hyperplastic-dysplastic) exhibited eosinophilia. Furthermore, the majority of the eosinophils associated with malignant epithelium were found to contain TGF-alpha mRNA. The number of TGF-alpha mRNAs containing eosinophils associated with malignant oral epithelium is significantly higher than that associated with nonmalignant oral epithelium. Together, these results suggest that eosinophils are recruited to tumor-developing sites, that they predominantly associate with malignant epithelium, and that most tumor-associated eosinophils express the cytokine TGF-alpha.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728410

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

Review 1.  Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review).

Authors:  Annette Affolter; Johann Kern; Karen Bieback; Claudia Scherl; Nicole Rotter; Anne Lammert
Journal:  Int J Oncol       Date:  2022-06-01       Impact factor: 5.884

Review 2.  Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxins.

Authors:  S M Rybak; H R Hoogenboom; D L Newton; J C Raus; R J Youle
Journal:  Cell Biophys       Date:  1992 Aug-Dec

3.  Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms.

Authors:  Mahmoud Said; Sam Wiseman; Jun Yang; Sadir Alrawi; Wade Douglas; Richard Cheney; Wesley Hicks; Nestor Rigual; Thom Loree; Gregory Spiegel; Dongfeng Tan
Journal:  BMC Clin Pathol       Date:  2005-01-07

4.  Quantitative Analysis of Tumor-associated Tissue Eosinophilia in Recurring Bladder Cancer.

Authors:  Hristo Popov; Ivan S Donev; Peter Ghenev
Journal:  Cureus       Date:  2018-09-10

5.  Tissue eosinophilia induced by recombinant human interleukin-5 in the hamster cheek pouch membrane.

Authors:  M Minnicozzi; W N Durán; D Kim; G J Gleich; J Wagner; R W Egan
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.